ELECTROPHYSIOLOGY — % Change
Products & Services · % ChangeJohnson & Johnson ELECTROPHYSIOLOGY — % Change remained flat by 0.0% to 9.3% in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 35.0%, from 14.3% to 9.3%. Over 2 years (FY 2022 to FY 2024), ELECTROPHYSIOLOGY — % Change shows an upward trend with a 17.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A positive percentage indicates accelerating sales growth, whereas a negative percentage suggests a contraction in market share or reduced demand for the product line.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the electrophysiology product...
Peer comparison
Comparable to segment-level revenue growth rates reported by diversified healthcare and medical device companies.
jnj_segment_electrophysiology_changeHistorical Data
| FY'22 | FY'23 | FY'24 | |
|---|---|---|---|
| Value | 26.8% | 57.1% | 37.1% |
| YoY Change | — | +113.1% | -35.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's electrophysiology — % change?
- Johnson & Johnson (JNJ) reported electrophysiology — % change of 9.3% in Q4 2024.
- How has Johnson & Johnson's electrophysiology — % change changed year-over-year?
- Johnson & Johnson's electrophysiology — % change decreased by 35.0% year-over-year, from 14.3% to 9.3%.
- What is the long-term trend for Johnson & Johnson's electrophysiology — % change?
- Over 2 years (2022 to 2024), Johnson & Johnson's electrophysiology — % change has grown at a 17.7% compound annual growth rate (CAGR), from 26.8% to 37.1%.
- What does electrophysiology — % change mean?
- The percentage change in revenue from electrophysiology products compared to a previous period.